Follow us:  linkedin twitter slideshare youtube google + pinterest

White Paper: Expanding a Product Portfolio without Cannibalizing an Established Brand


Pages/Slides: 6

Delivery Format: PDF

   Request a Quote

ID: BEB-42

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

Add to Cart

Please click on "Add to Cart" to obtain the white paper on "Expanding a Product Portfolio without Cannibalizing an Established Brand."

Owing to mounting competition, bio-pharmaceutical companies often expand their product portfolio in the same indication area. This may lead a new brand into gaining more popularity at the expense of an established brand. The challenge for all product and brand leaders is to expand their product portfolio such that introduction of a new product does not affect the sales of the established brand.

This white paper contains key excerpts from Best Practices, LLC benchmarking reports which are aimed at providing superior marketing and branding strategies.

If you would like to purchase the full study this summary is based on click here.

Industries Profiled:
Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research

Companies Profiled:
Pharma; Biotech; Medical Device Companies

Quick Links  

Follow us: 

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information